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Abstract
Our study, availing the new, agreed by the OECD and Eurostat lists of preventable and treatable 
causes of death, seeks to quantify the contribution of avoidable causes to premature mortality 
and its dynamics in Poland and Central European countries – Czechia, Hungary, Lithuania 
and Slovenia, in comparison with Sweden serving as a benchmark country in 1999–2017. We 
calculated age standardised death rates for the broad groups of avoidable causes and more 
specific ones, which comprised preventable and treatable cancer and diseases of the circulatory 
system (DCS), preventable injuries and alcohol-related diseases. Deaths from not avoidable 
causes were also analysed. The analysis of time trends in the death rates and calculation of 
the Average Annual Percent Change (AAPC) for the overall trend were performed with joint-
point models. The contribution of changes in mortality from avoidable causes to increase 
life expectancy during 1999–2017 and contribution of the difference in mortality from these 
causes to the difference in life expectancy between the five countries and Sweden were based 
on the decomposition of temporary life expectancy between birth and age 75 [e(0-75)]. For the 
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calculation of life expectancy, we used the classic Chiang method and the decomposition of 
life expectancy by the death causes and age was conducted with the Arriaga method. The 
AAPC of death rates from avoidable causes in 1999–2017 was similar in all the countries but 
Lithuania, where the decline started later. The decline in the death rates from not avoidable 
causes is much slower than the rates from avoidable causes. Mortality from treatable causes 
was decreasing faster than from preventable causes in most populations. In 1999–2017, the 
average rate of mortality decline for preventable cancer was greater among men than among 
women, while for treatable cancer the sex-related differences were much smaller and in favour 
of women. As for preventable and treatable death from DCS, their decrease was faster among 
women than men in all the countries but Sweden. Improvements in mortality from causes that 
could be avoided through prevention or treatment made substantial positive contributions 
to the overall change in life expectancy in all the countries. The differences in temporary life 
expectancy e(0-75) between the analysed Central European countries and Sweden were much 
smaller in 2017 than in 1999, due to the reduction of the gap in mortality from avoidable 
causes. Our results show that among men, and to a lesser extent among women, mortality 
from preventable causes contributes more than mortality from causes that can be effectively 
treated to shorter life expectancy in the countries of Central Europe than in Sweden.
This indicates that in reducing the health gap between the inhabitants of Central Europe and 
Western Europe, the healthcare system should consider disease prevention even to a greater 
extent than just treating them.
Keywords: avoidable mortality, premature mortality, mortality in Poland, mortality in Central 
Europe, avoidable cardiovascular mortality, avoidable cancer mortality
Introduction
Assuming as an axiom that the primary objective of the health system is to safeguard 
and improve the health of society, it is natural to assess this system in terms of its 
participation in improving the health of the population and assess its contribution 
to health differences between countries. This task is extremely difficult due to the 
complexity of the problem and the limitations resulting from the lack of relevant data. It is 
essential to choose a health indicator that is appropriately specific and sensitive to action 
and intervention in the area of health. The concept of avoidable deaths as it is commonly 
understood as a way of measuring the quality of healthcare was developed in the 1970s 
by a team led by Rutstein (Rutstein, Berenberg, Chalmers, Child, Fishman & Perrin, 
1976). They proposed to measure the quality of medical care by counting the cases of 
unnecessary illnesses and unnecessary premature deaths. The list of avoidable causes of 
deaths has been changing over the years. As Nolte and McKee (Nolte & McKee, 2004) 
have shown, almost each study on amenable mortality has had its own list of ‘causes of 
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deaths amenable to healthcare’. Eurostat started to report avoidable deaths indicators 
in 2014 (Eurostat, 2014), based on the lists developed by the Office of National Statistics 
(ONS) in England in 2011 (ONS, 2011). In 2018, the OECD and Eurostat worked 
together with an expert group to develop new joint lists of preventable and treatable 
causes of mortality that built on the results of earlier work. These lists were published 
in 2019 (OECD, Eurostat, 2019). Causes of death are considered preventable if they can 
be avoided mainly through effective public health and primary prevention interventions 
(to reduce incidence). The most important specific categories of preventable deaths 
include those caused by diseases that can be prevented by vaccination, HIV/AIDS, lung 
cancer, chronic obstructive pulmonary disease, diseases related to the consumption 
of alcohol and other psychoactive substances, as well as accident injuries and suicide. 
Causes of death are considered treatable (or amenable, as they were named earlier) if 
in the scope of the medical knowledge and available technology during death they can 
be mainly avoided through timely and effective healthcare interventions, including 
secondary prevention and treatment (to reduce case-fatality). Specific categories of 
causes of death that can be effectively treated include, but are not limited to, cancer 
of the breast, colon, rectum and anus, Hodgkin’s disease, benign neoplasm, acute and 
chronic rheumatic heart disease, pneumonia and acute lower respiratory tract infection, 
asthma, gastric ulcer and duodenal ulcer, diseases of the appendix, hernia. Unlike 
in the earlier versions, in the current version of the lists the age threshold has been 
uniformly set to 75 years for all the selected causes of death. Among the set principles 
there were also following three important ones: “For those causes of death that can be 
both largely prevented and also treated once they have occurred, these causes of death 
were attributed to the preventable category on the rationale that if these diseases are 
prevented, there would be no need for treatment. Causes of death should generally 
not be fractioned as being partly preventable and treatable given the lack of evidence 
to do this accurately and systematically, except when there is no strong evidence of 
predominance, in which case a 50%–50% allocation was used. Any double-counting of 
the same causes of death between the two lists was avoided, so that the two lists can be 
used together to provide a broad assessment of the relative importance of prevention 
and health care interventions in reducing avoidable deaths.” (OECD, Eurostat, 2019). 
The 50–50 allocation was applied to cervical cancer, diabetes mellitus, and most of 
selected avoidable diseases of the circulatory system (DCS), including ischaemic heart 
diseases and cerebrovascular diseases. All these principles make the new lists somewhat 
different than the earlier lists.
As the authors underline, both lists of causes of mortality and the age limits reflect 
current health expectations, medical technology and knowledge, and developments 
in health policy, and hence might be subject to future revisions.
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Based on earlier classifications, some publication analysed avoidable mortality 
in European countries (Gay, Paris, Devaux, & de Looper, 2011; Nolte, & McKee, 
2011; Velkova, Wolleswinkel-van den Bosch, & Mackenbach, 1997; Nolte, Scholz, 
Shkolnikov, & McKee, 2002), pointing out differences between countries in Central 
and Western Europe. The issue of avoidable deaths in accordance with the previous 
classification in relation to the situation in Poland was presented in two publications 
by Wróblewska (Wróblewska, 2012; Wróblewska, 2017), who stressed the importance 
of such an approach which can provide new information that cannot be obtained with 
the use of classic mortality rates. Recently Karanikolos and colleagues (Karanikolos, 
Mackenbach, Nolte, Stuckler, & McKee, 2018) investigated trends in amenable and other 
mortality in the EU since 2000 across 28 EU countries to check if the global financial 
crisis and its aftermath had an impact upon the performance of health systems in Europe.
Our study, availing the new agreed classifications, tries to quantify the contribution 
of avoidable causes of death to premature mortality and its dynamics in Poland and 
Central European countries – Czechia, Hungary, Lithuania and Slovenia, in comparison 
with Sweden serving as a benchmark country. The estimation of the share of preventable 
causes of death shows the magnitude of possible yield in health and life expectancy by 
strengthening and improving public health policy and the healthcare system.
Material and methods
Mortality and population data for all countries but Poland were extracted from 
the WHO Mortality data base for the years 1999–2017 when causes of death in the 
analysed countries were coded according to the 10th revision of the International 
Classification of Diseases – ICD-10 (WHO Health statistics and information systems, 
2019). Data for Poland come from databases of Statistics Poland that are made available 
with some restrictions to the National Institute of Public Health – National Institute 
of Hygiene to conduct statutory analysis of health status of the Polish population.
The selection of causes of death considered avoidable was based on the above-
mentioned OECD/Eurostat lists of preventable and treatable causes of death. In the 
analysis we considered three aggregated main groups of causes i.e. all avoidable, all 
preventable, all treatable, and the same categories for cancer and for diseases of the 
circulatory system (DCS). We also analysed mortality from preventable injuries and 
preventable alcohol-related causes.
We used the direct method to standardise the mortality rates by age and as a standard 
we used the European Standard Population developed by Eurostat (Eurostat, 2013), 
which has the same age structure for men and women.
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Since analysis of avoidable mortality is by definition constrained to the population 
below 75 years of age, the calculation of contribution of changes in mortality from 
avoidable causes to increase life expectancy is based on temporary life expectancy 
(partial life expectancy) between birth and age 75 [e (0-75)]. For the calculation of life 
expectancy, we used the classic Chiang method (Chiang, 1984) and the decomposition 
of the life expectancy in accordance with the death causes and age was conducted with 
the Arriaga method (Arriaga, 1984). The analysis of time trends in the death rates 
and calculation of the Average Annual Percent Change (AAPC) for the overall trend 
and 95% confidence intervals (95% CI) were performed with joint point models and 
the joint point Regression Program (Version 4.8.0.1 April 22, 2020; National Cancer 
Institute, USA). The AAPC summarises the rates of change in age-adjusted rates that 
are not constant over a given time (in our case 1999–2017) but vary among different 
time partitions. The AAPC is the geometric mean of the annual changes from all the 
time partitions (Clegg, Hankey, Tiwari, Feuer, & Edwards, 2009).
Results
Unfavourable differences in the temporary life expectancy of men in Poland and 
other Central European countries compared to the inhabitants of Sweden, although 
clearly decreasing, are still visible, especially among men (Figure 1). 
Figure 1.  Temporary life expectancy of men and women in Czechia, Hungary, 
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The increase in temporary life expectancy, resulting from the decline of premature 
mortality, was not uniform in the analysed countries. If we assume that the maximum 
possible increase can lead to life expectancy of 75 years, the greatest relative increase 
in life expectancy occurred in Slovenia – 40% and 33% of the ‘missing’ years of life 
for men and women, respectively. Among women, a relative increase in temporary 
life expectancy in all the countries was greater than in Sweden, and among men only 
in Lithuania it was smaller than in Sweden.
Mortality level and its changes
Deaths from avoidable causes account for as much as 79% and 78% of all death 
cases in the population below 75 years of age in Hungary and Lithuania, respectively, 
and about 65% in Poland and Sweden (Figure 2). 
Figure 2.  Percentage of avoidable deaths by subgroups of causes among all deaths 

















































Czechia Hungary Lithuania Poland Slovenia Sweden Czechia Hungary Lithuania Poland Slovenia Sweden
Preventable Treatable
Cancer Circulatory Injuries Alcohol Other
Source: own elaboration.
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More than 60% of avoidable deaths is caused by preventable causes, in the range 
from 60.5% in Czechia to 71.0% in Slovenia. Diseases of the circulatory system 
contribute more to avoidable deaths than cancer in Czechia, Hungary and especially 
in Lithuania, while in Slovenia, Sweden, and Poland the situation is opposite. In 
Lithuania, some 42% of all premature deaths, i.e. below the age of 75, that could be 
avoided are caused by the DCS and about 23% are caused by cancer. In Slovenia the 
opposite is true.
In the period of 1999–2017, age-standardised mortality rates from avoidable causes 
show a clear decline at a similar pace (AAPC) in all the countries except Lithuania, 
where a decrease started only after 2007 (Figure 3). However, the decline in Lithuania 
during 2007–2017 was even faster than in other countries during 1999–2017 (–3.8, 
CI –5.2, –2.4). Overall, the mortality rates have the lowest values in Sweden and are 
the largest in Lithuania and Hungary – in 2017 2.7 times larger than in Sweden. In 
the entire analysed period, the avoidable rates for Poland were larger than those for 
Slovenia and since 2005 also larger than for Czechia.
Figure 3.  Mortality from avoidable causes of death in Czechia, Hungary, Lithuania, 
Poland, Slovenia, and Sweden, 1999–2018 – age-standardised rates and the 











































































Hungary Lithuania Poland Czechia Slovenia Sweden
Lithuania             -1.5 (-2.1; -0.9)
Hungary              -2.6 (-3.3; -1.8)
Poland                -2.4 (-2.9; -2.0)
Czechia               -2.9 (-3.1; -2.8)
Slovenia              -3.0 (-3.2; -2.8)
Sweden               -2.5 (-2.8; -2.3)
Source: own elaboration.
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A similar situation occurs in the case of preventable and treatable mortality 
(Figures 4 and 5). As for the former group of causes, the AAPC in Lithuania was 
significantly smaller than in Czechia and Slovenia, while for the latter the pace of 
decline of the rates in Lithuania was significantly slower than in all other countries. 
The treatable mortality decline in Poland was significantly slower than in Czechia and 
Slovenia. As in the case of total avoidable mortality, also in the case of preventable and 
treatable deaths the decline in Lithuania during 2007–2017 was faster than in other 
countries during 1999–2017 (AAPC –4.2, CI –5.3, –3.1 and –2.9, CI –3.6, –2.1, for 
preventable and treatable mortality, respectively).
Figure 4.  Mortality from preventable causes of death in Czechia, Hungary, Lithuania, 
Poland, Slovenia, and Sweden, 1999–2018 – age-standardised rates and the 








































































Hungary Lithuania Poland Czechia Slovenia Sweden
Lithuania             -1.7 (-2.3; -1.1)
Hungary              -2.5 (-3.3; -1.7)
Poland                -2.3 (-2.7; -1.9)
Czechia               -2.5 (-2.7; -2.4)
Slovenia              -2.4 (-2.6; -2.3)
Sweden               -2.0 (-2.3; -1.6)
Source: own elaboration.
Mortality rates from not avoidable causes display different patterns than the rates 
from avoidable causes (Figure 6). First, in Poland they are much higher than in other 
countries and second, in all the countries their decline is much slower than the rates 
from avoidable causes. The only exception is Slovenia due to the fast decline of the 
rates that took place in 2003–2008.
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Figure 5.  Mortality from treatable causes of death in Czechia, Hungary, Lithuania, 
Poland, Slovenia, and Sweden, 1999–2018 – age-standardised rates and the 









































































Lithuania Hungary Poland Czechia Slovenia Sweden
Lithuania             -1.1 (-1.7; -0.5)
Hungary              -2.9 (-3.5; -2.3)
Poland                -2.7 (-3.1; -2.4)
Czechia               -3.5 (-3.6; -3.3)
Slovenia              -4.1 (-4.3; -3.9)
Sweden               -3.1 (-3.4; -2.8)
Source: own elaboration.
The mortality rates from avoidable causes in 1999 and 2017 and the pace of their 
decline among men and women in 1999–2017 are presented in Tables 1a and 1b. There 
are a few observations worth paying attention to. Death rates from preventable and 
treatable causes are higher in men than in women in all the countries. The decline 
in the rates in 1999–2017 was faster in the male population than among females for 
both groups of causes in Sweden and Slovenia. In Lithuania, on the other hand, the 
rates decreased faster among women than among men. Mortality from treatable causes 
was decreasing faster than from preventable causes among men and women in all 
the countries with the exception of men in Lithuania and Hungary. Even though all 
female mortality rates were lower than those among men, the proportion of deaths 
from treatable causes as well as not avoidable causes in all premature deaths (below 
75 years of age) was greater in the female population.
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Figure 6.  Mortality from not avoidable causes of death in Czechia, Hungary, 
Lithuania, Poland, Slovenia, and Sweden, 1999–2018 – age-standardised 





































































Poland Lithuania Hungary Czechia Slovenia Sweden
Poland                -1.0 (-1.6; -0.4)
Lithuania              0.1 (-0.4; 0.6)
Hungary              -0.7 (-1.3; -0.0)
Czechia               -0.3 (-0.5; -0.1)
Slovenia              -3.0 (-4.1; -1.9)
Sweden               -0.6 (-0.8; -0.5)
Source: own elaboration.
Table 1a.  Age-standardised death rates from avoidable and not avoidable causes 
among men in 1999 and 2017, their average annual percentage change 





AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Avoidable
1999 767.8 1195.3 1086.7 806.8 650.6 386.7
2017 456.8 730.5 798.6 502.8 358.9 224.0
AAPC –3.0 –2.7 –1.3 –2.6 –3.3 –2.9
95% CI –3.1; –2.8 –3.3; –2.1 –1.9; –0.7 –2.9; –2.3 –3.5; –3.1 –3.2; –2.6
%1999 81.7 85.6 85.6 71.0 73.0 74.5
%2017 73.2 80.6 80.1 65.3 72.5 66.2





AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Preventable
1999 473.7 821.5 756.5 530.5 449.1 244.3
2017 294.1 496.8 529.6 335.8 272.2 151.3
AAPC –2.7 –2.7 –1.6 –2.5 –2.9 –2.4
95% CI –2.9; –2.6 –3.4; –2.1 –2.2; –1.0 –2.9; –2.2 –3.1; –2.6 –2.9; –2.0
%1999 50.4 58.8 59.6 46.7 50.4 47.0
%2017 47.1 54.8 53.1 43.6 55.0 44.7
Treatable
1999 294.0 373.8 330.2 276.2 201.5 142.4
2017 162.7 233.7 269.0 167.0 86.7 72.7
AAPC –3.3 –2.6 –0.7 –2.8 –4.5 –3.6
95% CI –3.5; –3.2 –3.4; –1.8 –1.3; –0.0 –3.4; –2.2 –4.7; –4.2 –3.9; –3.3
%1999 31.3 26.8 26.0 24.3 22.6 27.4
%2017 26.1 25.8 27.0 21.7 17.5 21.5
Not 
avoidable
1999 171.5 200.8 183.4 328.9 240.7 132.7
2017 167.3 175.5 198.6 267.6 136.0 114.5
AAPC –0.3 –0.8 0.4 –1.0 –3.4 –0.7
95% CI –1.5; –0.1 –1.6; 0.1 –0.3; 1.0 –1.7; –0.3 –4.5; –2.2 –0.9; –0.6
%1999 18.3 14.4 14.4 29.0 27.0 25.5
%2017 26.8 19.4 19.9 34.7 27.5 33.8
Source: own elaboration.
Table 1b.  Age-standardised death rates from avoidable and not avoidable causes 
among women in 1999 and 2017, their average annual percentage change 





AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Avoidable
1999 348.9 507.3 399.1 327.3 278.5 205.8
2017 203.7 329.6 273.9 214.4 159.6 146.3
AAPC –3.1 –2.6 –1.8 –2.4 –3.0 –1.9
95% CI –3.3; –2.9 –3.3; –1.9 –3.3; –0.2 –2.8; –1.9 –3.4; –2.6 –2.3; –1.5
%1999 77.3 82.0 80.8 68.0 68.7 69.2
%2017 68.0 77.0 74.7 64.1 66.8 64.5
Preventable
1999 163.1 275.4 211.6 160.4 141.3 108.2
2017 107.7 192.4 145.9 113.5 94.6 84.9
AAPC –2.4 –2.2 –1.8 –2.0 –2.3 –1.3
95% CI –2.7; –2.0 –2.9; –1.5 –3.1; –0.5 –2.6; –1.1 –2.8; –1.7 –1.7; –0.9
%1999 36.1 44.5 42.9 33.3 34.8 36.4
%2017 36.0 44.9 39.8 34.0 39.6 37.4





AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Treatable
1999 185.8 232.0 187.5 166.9 137.2 97.6
2017 96.0 137.3 128.0 100.8 65.0 61.5
AAPC –3.8 –2.8 –1.8 –3.0 –3.9 –2.7
95% CI –4.0; –3.6 –3.2; –2.5 –2.3; –1.2 –3.4; –2.6 –4.2; –3.5 –2.9; –2.6
%1999 41.2 37.5 38.0 34.6 33.8 32.8
%2017 32.1 32.1 34.9 30.2 27.2 27.1
Not 
avoidable
1999 102.4 111.3 94.7 154.4 127.0 91.7
2017 95.8 98.4 92.7 119.8 79.2 80.7
AAPC –0.5 –0.7 –0.4 –1.3 –2.7 –0.6
95% CI –0.8; –0.3 –1.3; –0.0 –0.8; –0.0 –1.8; –0.9 –3.9; –1.4 –0.8; –0.5
%1999 22.7 18.0 19.2 32.0 31.3 30.8
%2017 32.0 23.0 25.3 35.9 33.2 35.5
Source: own elaboration.
Table 2a.  Age-standardised death rates from subgroups of avoidable causes among 
men in 1999 and 2017, their average annual percentage change (AAPC, 




AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Avoidable 
cancer
1999 212.1 293.6 212.3 207.5 198.0 88.9
2017 124.4 216.3 165.8 152.3 130.4 62.7
AAPC –3.0 –1.5 –1.1 –1.6 –2.1 –1.7
95% CI –3.4; –2.7 –1.7;–1.3 –1.3; –0.9 –1.9; –1.2 –2.4; –1.8 –2.1; –1.4
Preventable 
cancer
1999 158.2 234.4 178.1 175.6 160.8 66.5
2017 94.3 167.4 138.7 121.4 109.2 46.2
AAPC –3.0 –1.7 –1.1 –1.9 –2.1 –1.8
95% CI –3.1; –2.8 –1.9; –1.5 –1.4; –0.9 –2.2; –1.6 –2.4; –1.8 –2.3–1.4
Treatable 
cancer
1999 54.0 59.3 34.2 31.9 37.1 22.3
2017 30.1 48.9 27.1 30.9 21.3 16.6
AAPC –3.4 –0.7 –1.1 –0.2 –2.0 –1.6
95% CI –4.0; –2.8 –1.0; –0.5 –1.8; –0.4 –0.5; 0.1 –2.8; –1.2 –1.9; –1.3
Avoidable 
circulatory
1999 374.3 497.3 448.0 352.7 212.9 182.0
2017 162.9 284.6 348.7 160.5 94.8 72.9
AAPC –4.5 –3.1 –1.0 –4.3 –4.5 –4.9
95% CI –4.6; –4.3 –4.0; –2.2 –1.6; –0.5 –4.8; –3.8 –5.0; –4.0 –5.2; –4.6
Preventable 
circulatory
1999 178.3 242.3 217.4 170.0 102.6 88.4
2017 77.9 140.6 169.7 78.1 45.4 35.3
AAPC –4.4 –3.0 –1.0 –4.3 –4.5 –4.9
95% CI –4.6; –4.3 –3.9; –2.2 –1.5; –0.4 –4.9; –3.7 –5.1; –4.0 –5.2; –4.6





AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Treatable 
circulatory
1999 196.0 255.0 230.6 182.7 110.3 93.6
2017 85.0 144.1 179.0 82.4 49.3 37.6
AAPC –4.5 –3.0 –1.0 –4.4 –4.5 –4.8
95% CI –4.6; –4.3 –3.6; –2.4 –1.6; –0.5 –4.9; –3.8 –5.0; –4.0 –5.2; –4.5
Preventable 
injuries
1999 79.2 130.5 248.8 103.8 105.7 39.4
2017 51.9 63.9 125.5 62.8 49.2 29.1
AAPC –2.5 –3.7 –3.4 –2.7 –4.5 –1.6




1999 31.6 154.0 55.8 42.6 34.7 19.6
2017 33.8 62.3 57.5 48.8 49.6 13.2
AAPC 0.3 –4.9 0.8 0.7 1.1 –2.1
95% CI –0.7; 1.3 –6.1; –3.7 –1.3; 3.1 –0.6; 2.1 –3.3; 5.7 –3.3; –0.8
Source: own elaboration.
Table 2b.  Age-standardised death rates from subgroups of avoidable causes among 
women in 1999 and 2017, their average annual percentage change (AAPC, 




AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Avoidable 
cancer
1999 107.5 137.2 95.2 91.1 99.5 79.1
2017 76.1 125.7 75.5 95.5 83.7 67.8
AAPC –2.0 –0.3 –1.1 0.1 –0.9 –1.0
95% CI –2.3; –1.8 –0.7; 0.1 –1.4; –0.8 0.0; 0.3 –1.2; –0.6 –1.3; –0.7
Preventable 
cancer
1999 42.4 62.4 36.6 41.0 41.1 35.2
2017 39.1 70.0 32.9 49.1 46.8 35.1
AAPC –0.6 0.7 –0.4 0.9 0.7 –0.1
95% CI –0.8; –0.3 0.0; 1.3 –1.2; 0.3 0.8; 1.1 0.1; 1.2 –0.7; 0.4
Treatable 
cancer
1999 65.1 74.8 58.5 50.1 58.4 43.8
2017 37.0 55.7 42.7 46.5 36.8 32.7
AAPC –2.9 –1.5 –1.5 –0.6 –2.3 –1.8
95% CI –3.9; –2.0 –1.9; –1.2 –2.0; –1.0 –0.8; –0.3 –2.7; –1.8 –2.1; –1.4
Avoidable 
circulatory
1999 174.1 233.6 188.9 156.9 93.6 72.2
2017 63.4 116.7 117.0 59.1 34.3 31.9
AAPC –5.6 –3.8 –2.3 –5.3 –5.0 –4.6
95% CI –5.9; –5.3 –4.3; –3.4 –2.7; –1.9 –5.9; –4.7 –5.8; –4.2 –5.1; –4.0
Preventable 
circulatory
1999 79.6 111.7 87.8 74.0 44.2 33.5
2017 28.8 57.0 56.3 28.3 15.7 15.0
AAPC –5.6 –3.6 –2.2 –5.2 –5.1 –4.6
95% CI –5.9; –5.3 –4.2; –3.0 –2.6; –1.7 –5.8; –4.6 –5.9; –4.2 –5.1; –4.0





AAPC Czechia Hungary Lithuania Poland Slovenia Sweden
Treatable 
circulatory
1999 94.5 122.0 101.2 82.9 49.4 38.6
2017 34.6 59.7 60.6 30.8 18.6 16.9
AAPC –5.6 –4.0 –2.4 –5.6 –4.9 –4.6
95% CI –5.9; –5.3 –4.4; –3.5 –2.8; –2.0 –5.8; –5.3 –5.8; –4.1 –5.2; –4.0
Preventable 
injuries
1999 21.1 32.5 51.7 21.8 29.3 12.6
2017 12.4 15.2 26.7 11.7 12.9 9.0
AAPC –3.4 –4.3 –3.6 –3.4 –4.5 –2.1




1999 9.3 42.1 20.9 9.8 10.9 5.7
2017 11.5 16.5 17.7 12.7 10.1 5.3
AAPC 0.9 –4.9 1.0 1.5 –1.0 –1.1
95% CI 0.2; 1.6 –6.6; –3.2 –2.0; 4.0 –0.9; 3.9 –3.2; 1.3 –1.8; –0.5
Source: own elaboration.
Among men, mortality from avoidable cancer causes is lower than mortality from 
avoidable DCS in all the countries but Slovenia (Table 2a and 2b). The opposite is 
true for women, among whom mortality from avoidable cancer causes is higher than 
mortality from avoidable DCS in all the countries but Lithuania. Death rates from 
preventable cancer causes are higher than from treatable cancer in all the populations 
but women in Lithuania and are higher than death rates from preventable DCS 
in all the populations but men and women in Lithuania. On the other hand, death 
rates from treatable cancer are lower than from treatable DCS among men in the all 
countries and women in Lithuania and Hungary.
In 1999–2017, the average rate of mortality decline for preventable cancer was 
greater among men than among women, while for treatable cancer the sex-related 
differences were much smaller and in favour of women with the exception of Czechia’s 
residents. As for preventable and treatable death from the DCS, its decrease was faster 
among women than men in all the countries except Sweden.
It should be noted that mortality from alcohol-related diseases of the Hungarian 
population decreased significantly in the analysed period., In the case of Lithuanian 
residents, on the other hand, the AAPC index showed a slight change in the death 
rate throughout the period, however, it resulted from opposite trends in the initial 
years, when the mortality rate increased until 2007 and after 2007, when the mortality 
rates had a clear, significant downward trend and the average decline rate was –6.7% 
for men and –6.8% for women.
Improvements in mortality from causes that could be avoided through prevention 
or treatment made substantial positive contributions to the overall change in  life 
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expectancy in all the countries. Among men, the most important was declining 
mortality from preventable causes, especially injuries, a slightly smaller contribution 
was due to the decline in preventable cancer and the DCS (Figure 7a). Among women, 
the decrease in mortality from causes amenable to medical intervention contributed 
the most to the increase in life expectancy in four countries and only in Hungary 
and Lithuania the reduction in the number of death cases from preventable causes 
played a larger role (Figure 7b). In Hungary, a large role was played by the reduction 
in mortality from injuries and from alcohol-related causes of death and in Lithuania, 
the reduction of mortality from injuries played an essential role.
The declining mortality from avoidable DCS contributed to more months of life 
than the change in avoidable mortality from cancer in both men and women. The 
contribution of the decrease in mortality from treatable DCS to life expectancy is larger 
than the contribution from preventable DCS causes in all the populations. However, 
the situation is different with cancer mortality. Among men, the role of the decrease 
in mortality from preventable cancer is larger than that of the reduction in treatable 
cancer mortality, while among women the reverse is true. In Poland and Slovenia, 
female preventable cancer mortality did not contribute to a life expectancy increase.
Figure 7a.  Cause-specific contributions to change in men’s temporary life expectancy 
in Czechia, Hungary, Lithuania, Poland, Slovenia, and Sweden, 1999–2017
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Figure 7b.  Cause-specific contributions to change in women’s temporary life 




























































Cancer Circulatory Injuries Other Not Avoid
Source: own elaboration.
Differences in temporary life expectancy e(0-75) between the analysed Central 
European countries and Sweden were much smaller in 2017 than in 1999, due to the 
reduction of the gap in mortality from avoidable causes (Figures 8a, 8b, 9a and 
9b). In four countries apart from Slovenia and Poland, the difference in mortality 
due to not avoidable causes in 2017 was similar to that in 1999. Among men and, 
to a  lesser extent, among women, mortality from preventable causes is much 
more detrimental than mortality from causes that can be effectively treated. This 
is especially true in Lithuania and Hungary. It is worth noting that while in 1999 
higher mortality from avoidable deaths due to the DCS contributed more than due 
to cancer to shorter life expectancy of men and women in Poland than in Sweden, 
in 2017 cancer played a more negative role among men because of the unfavourable 
situation in preventable mortality.
Preventable cancer diseases contribute more to the shorter life span of 0–75 years 
among men in Central Europe compared to those in Sweden than preventable DCS. 
The higher mortality due to injuries, especially in Lithuania, as well as alcohol-related 
diseases also play a noticeable negative role.
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Figure 8a.  Preventable causes specific contribution to the difference in men’s 
temporary life expectancy in Czechia, Hungary, Lithuania, Poland, 
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Source: own elaboration.
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Figure 8b.  Treatable causes specific contribution to the difference in men’s temporary 
life expectancy in Czechia, Hungary, Lithuania, Poland, and Slovenia 
in relation to Sweden in 1999 and 2017
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Source: own elaboration.
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Figure 9a.  Preventable causes specific contribution to the difference in women’s 
temporary life expectancy in Czechia, Hungary, Lithuania, Poland, and 
Slovenia in relation to Sweden in 1999 and 2017
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Figure 9b.  Treatable causes specific contribution to the difference in women’s 
temporary life expectancy in Czechia, Hungary, Lithuania, Poland, 
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a) Due to very narrow segments there is insufficient distinction for Slovenia: treatable circulatory causes 0.1 month 
of life and not avoidable causes 0.1 month of life in 2017
Source: own elaboration.
Conclusion
Improving population health is the primary goal of healthcare systems, therefore, 
a more precise quantification of healthcare systems performance and contribution 
to the health of the population is highly desirable. As emphasised by Nolte and 
McKee (Nolte & McKee, 2003), the concept of amenable mortality, in addition to its 
attractive conceptual design, provides new information that is not directly reflected 
in general mortality indicators traditionally used to measure the outcomes of healthcare 
systems. Korda & Butler (2006), concluding their analysis of trends in avoidable 
mortality in Australia and comparisons with Western Europe, wrote that the trends 
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in avoidable mortality in Australia suggested that the Australian healthcare system had 
been effective in improving population health and Australia’s experience compared 
favourably with that of Europe.
In our study, availing the new, recently agreed by the OECD and Eurostat lists 
of preventable and treatable causes of death, we tried to quantify the contribution 
of avoidable causes to premature mortality and its dynamics in Poland and Central 
European countries – Czechia, Hungary, Lithuania, and Slovenia, in comparison with 
Sweden serving as a benchmark country in 1999–2017. Publication of the lists agreed 
by the experts of the OECD and Eurostat gives a new push to comparative analyses of 
avoidable mortality in the countries and, therefore, assessment of the performance of 
their healthcare systems. Using different lists may lead to not identical conclusions, 
as has been shown by Gay and colleagues (Gay et al 2011), so the comparison of the 
results obtained with the use of the new lists may not be advisable.
Higher premature mortality among men than women, especially strongly marked 
in Central European countries, is a well-known and documented phenomenon (for 
example European Commission, 2011; WHO, 2018) yet, it still needs more attention 
(Baker, Dworkin, Tong, Banks, Shande, & Yameyf, 2014). Our results show that 
mortality from premature avoidable causes is higher among men than women and 
the excess of male mortality did not decline in Czechia and Lithuania in 1999–2017 
and decreased relatively little in the other countries.
Analysing the decline of avoidable mortality in Europe in 1955–1994 (however, 
without then socialist countries) Simonato and colleagues (Simonato, Ballard, 
Bellini, & Winkelmann, 1998) found that the decline in mortality from causes amenable 
to medical treatment had the most pronounced impact, while much smaller was the 
impact of the decline in preventable causes. They emphasised that a further reduction 
in avoidable mortality could be achieved through implementation of primary and 
secondary prevention. We also have observed that the pace of the decline in death 
rates from treatable causes was greater than the death rates from preventable causes 
in all the analysed countries but Lithuania. One may conclude, therefore, that the 
two-decade old plea for prevention by Simonato and colleagues is still timely and 
very relevant. Wróblewska (2012) drew a similar conclusion while analysing the 
situation in Poland in 1999–2008. This problem is particularly pressing in the case 
of cancer. Among men, preventable cancer mortality is much higher than mortality 
due to treatable cancer, but their pace of decline is quite similar. Among women, 
both groups are of similar magnitude, however, there was no significant progress 
of improvement in female preventable cancer mortality in the analysed countries 
(including Sweden) except Czechia. In fact, in Poland, Hungary, and Slovenia the 
rates had a significant upward trend. Finally, it is worth emphasising that among men 
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and, to a lesser extent, among women, mortality from preventable causes is more 
responsible for shorter temporary life expectancy in Czechia, Hungary, Lithuania, 
Poland, and Slovenia than in Sweden, as compared to mortality from causes that can 
be effectively treated. Finally, it is worth emphasising that mortality from preventable 
causes is more responsible than mortality from causes that can be effectively treated 
for the shorter temporary life expectancy of men, and, to a lesser extent, of women, 
in the analysed Central European countries than among the inhabitants of Sweden.
While amenable mortality may be a relevant indicator, it has several limitations 
and one of those important is related to the quality and comparability of data. Different 
practices in assigning ICD codes as an underlying cause of death across countries and 
across time may reduce cross-country comparability. This problem, however, is present 
in any study using mortality data to make comparisons over time or across countries. 
From the Polish perspective, one of the important issues is the use of so called ‘garbage 
codes’ for coding deaths from diseases of the circulatory system. The frequent use 
of the heart failure (ICD-10 I50) as the underlying cause leads to underestimation 
of ischemic heart disease as a cause of death in Poland, which equally reduces the 
rates of preventable and treatable mortality equally split between the two categories. 
In 2016–2017 age standardised death rates from heart failure among men below 
75 years of age (per 100,000 population) were 52.4 in Poland, while 20.1, 10.3, 0.8, 
0.2, 2.8 and 2.6 in Czechia, Hungary, Lithuania, Slovenia, and Sweden, respectively. 
Deaths from ill-defined conditions (ICD-10 R96-R99) could exert a similar influence 
(among Polish men 77.6, while among men in Czechia, Hungary, Lithuania, Slovenia, 
and Sweden 12.4, 1.4, 27.3, 19.1 and 11.2, respectively).
Some limitation related to the concept of treatable mortality results, among 
others, from the fact that mortality from treatable causes depends on the prevalence 
of disease and its case fatality. Therefore, it is possible that the observed differences 
between the countries’ treatable mortality rates or their changes over time are affected 
by the differences or changes in disease prevalence rather than its treatment (see for 
example Gierlotka et al., 2015).
Considering various weaknesses and limitations of the concept of avoidable deaths, 
the obtained results of the analysis should be interpreted with caution. Nevertheless, 
several of our observations may be helpful in assessing the problem of premature 
mortality and the operation of the healthcare system in Poland and other analysed 
countries. Undoubtedly, the healthcare system in Poland can still do a lot to reduce the 
premature mortality of Polish residents and extend their life expectancy to diminish 
the distance in relation to many other European countries. Reduction in the excess 
male mortality in relation to women is also very much expected and needed.
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